Designing protein-binding proteins with high affinity is critical in biomedical research and biotechnology. Despite recent advancements targeting specific proteins, the ability to create high-affinity binders for arbitrary protein targets on demand, without extensive rounds of wet-lab testing, remains a significant challenge. Here, we introduce PPDiff, a diffusion model to jointly design the sequence and structure of binders for arbitrary protein targets in a non-autoregressive manner. PPDiffbuilds upon our developed Sequence Structure Interleaving Network with Causal attention layers (SSINC), which integrates interleaved self-attention layers to capture global amino acid correlations, k-nearest neighbor (kNN) equivariant graph layers to model local interactions in three-dimensional (3D) space, and causal attention layers to simplify the intricate interdependencies within the protein sequence. To assess PPDiff, we curate PPBench, a general protein-protein complex dataset comprising 706,360 complexes from the Protein Data Bank (PDB). The model is pretrained on PPBenchand finetuned on two real-world applications: target-protein mini-binder complex design and antigen-antibody complex design. PPDiffconsistently surpasses baseline methods, achieving success rates of 50.00%, 23.16%, and 16.89% for the pretraining task and the two downstream applications, respectively. The code, data and models are available at https://github.com/JocelynSong/PPDiff.

Abstract--Recent breakthroughs in generative modeling have demonstrated remarkable capabilities in molecular generation, yet the integration of comprehensive biomedical knowledge into these models has remained an untapped frontier . In this study, we introduce K-DREAM (Knowledge-Driven Embedding-Augmented Model), a novel framework that leverages knowledge graphs to augment diffusion-based generative models for drug discovery. By embedding structured information from large-scale knowledge graphs, K-DREAM directs molecular generation toward candidates with higher biological relevance and therapeutic suitability. This integration ensures that the generated molecules are aligned with specific therapeutic targets, moving beyond traditional heuristic-driven approaches. In targeted drug design tasks, K-DREAM generates drug candidates with improved binding affinities and predicted efficacy, surpassing current state-of-the-art generative models. It also demonstrates flexibility by producing molecules designed for multiple targets, enabling applications to complex disease mechanisms. Impact Statement--We introduce K-DREAM, a new approach to drug discovery that combines knowledge graphs with AIdriven drug design. Unlike conventional methods that focus mainly on chemical properties, our framework incorporates biological relationships to create more medically relevant drug candidates.

We present the Boltzmann classifier, a novel distance based probabilistic classification algorithm inspired by the Boltzmann distribution. Unlike traditional classifiers that produce hard decisions or uncalibrated probabilities, the Boltzmann classifier assigns class probabilities based on the average distance to the nearest neighbors within each class, providing interpretable, physically meaningful outputs. We evaluate the performance of the method across three application domains: molecular activity prediction, oxidation state classification of transition metal complexes, and breast cancer diagnosis. In the molecular activity task, the classifier achieved the highest accuracy in predicting active compounds against two protein targets, with strong correlations observed between the predicted probabilities and experimental pIC50 values. For metal complexes, the classifier accurately distinguished between oxidation states II and III for Fe, Mn, and Co, using only metal-ligand bond lengths extracted from crystallographic data, and demonstrated high consistency with known chemical trends. In the breast cancer dataset, the classifier achieved 97% accuracy, with low confidence predictions concentrated in inherently ambiguous cases. Across all tasks, the Boltzmann classifier performed competitively or better than standard models such as logistic regression, support vector machines, random forests, and k-nearest neighbors. Its probabilistic outputs were found to correlate with continuous physical or biological properties, highlighting its potential utility in both classification and regression contexts. The results suggest that the Boltzmann classifier is a robust and interpretable alternative to conventional machine learning approaches, particularly in scientific domains where underlying structure property relationships are important.

Exhaustive virtual screening is highly informative but often intractable against the expensive objective functions involved in modern drug discovery. This problem is exacerbated in combinatorial contexts such as multi-vector expansion, where molecular spaces can quickly become ultra-large. Here, we introduce Scalable Active Learning via Synthon Acquisition (SALSA): a simple algorithm applicable to multi-vector expansion which extends pool-based active learning to non-enumerable spaces by factoring modeling and acquisition over synthon or fragment choices. Through experiments on ligand-and structure-based objectives, we highlight SALSA's sample efficiency, and its ability to scale to spaces of trillions of compounds. Further, we demonstrate application toward multi-parameter objective design tasks on three protein targets - finding SALSA-generated molecules have comparable chemical property profiles to known bioactives, and exhibit greater diversity and higher scores over an industry-leading generative approach. Given the strong association between a molecule's core scaffold and its chemical properties, a common workflow is to iteratively design, make, and test changes at targeted R-groups in order to advance therapeutics through the discovery pipeline (Schneider, 2017). Exhaustive virtual screening of R-group changes aids designers and medicinal chemists in the search for promising, synthesizable molecular structures, but quickly becomes intractable against computationally expensive scores as the number of possible attachments increases.

Virtual Screening is an essential technique in the early phases of drug discovery, aimed at identifying promising drug candidates from vast molecular libraries. Recently, ligand-based virtual screening has garnered significant attention due to its efficacy in conducting extensive database screenings without relying on specific protein-binding site information. Obtaining binding affinity data for complexes is highly expensive, resulting in a limited amount of available data that covers a relatively small chemical space. Moreover, these datasets contain a significant amount of inconsistent noise. It is challenging to identify an inductive bias that consistently maintains the integrity of molecular activity during data augmentation. To tackle these challenges, we propose S-MolSearch, the first framework to our knowledge, that leverages molecular 3D information and affinity information in semi-supervised contrastive learning for ligand-based virtual screening. Drawing on the principles of inverse optimal transport, S-MolSearch efficiently processes both labeled and unlabeled data, training molecular structural encoders while generating soft labels for the unlabeled data. This design allows S-MolSearch to adaptively utilize unlabeled data within the learning process. Empirically, S-MolSearch demonstrates superior performance on widely-used benchmarks LIT-PCBA and DUD-E.

Large Language Models (LLMs) have demonstrated great performance in few-shot In-Context Learning (ICL) for a variety of generative and discriminative chemical design tasks. The newly expanded context windows of LLMs can further improve ICL capabilities for molecular inverse design and lead optimization. To take full advantage of these capabilities we developed a new semi-supervised learning method that overcomes the lack of experimental data available for many-shot ICL. Our approach involves iterative inclusion of LLM generated molecules with high predicted performance, along with experimental data. We further integrated our method in a multi-modal LLM which allows for the interactive modification of generated molecular structures using text instructions. As we show, the new method greatly improves upon existing ICL methods for molecular design while being accessible and easy to use for scientists.